Amount Raised
$200 Million
Round Type
Funding Round
Long BeachBiotechnologyHealth CareTherapeuticsDescription
Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that the company has entered into a $160 million revenue interest purchase and sale agreement for its investigational product tapinarof with three participants that include Marathon Asset Management (Marathon), NovaQuest Capital Management (NovaQuest) and a third institutional investor located in Boston. The company concurrently entered into a $40 million senior secured credit facility with the Boston-based firm. Tapinarof is a novel, therapeutic aryl hydrocarbon receptor modulating agent, in development as a once-daily, steroid-free and cosmetically elegant topical cream being investigated for the treatment of plaque psoriasis and atopic dermatitis.
Quick answer
Dermavant raised $200 Million in a Funding Round round, dated June 7, 2021. Dermavant is based in Long Beach, California, United States.
- How much did Dermavant raise?
- Dermavant raised $200 Million in a Funding Round round on June 7, 2021.
- What does Dermavant do?
- Dermavant is a biopharmaceutical company that specializes in developing innovative therapies for dermatological conditions.
- Where is Dermavant based and how big is it?
- Dermavant is based in Long Beach, California, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Dermavant that raised within 45 days of this round, from Fundz verified event records.
- Turnstone Biologics Corp raised $80M (Series D) on July 21, 2021.
- Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.
- Century Therapeutics raised $11M on July 19, 2021.
- Turnstone Biologics Corp raised $80M on July 14, 2021.
- Nimbus Therapeutics raised $105M (Funding Round) on July 13, 2021.
- Azora Therapeutics, Inc. (DE) raised $500K on July 12, 2021.
Who to call at Dermavant, and when
A new round usually means Dermavant is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Dermavant raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dermavant, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dermavant. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dermavant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Dermavant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.